3,5-BIS(PERFLUOROPROPYL)PYRAZOLE
- $45 - $725
- Product name: 3,5-BIS(PERFLUOROPROPYL)PYRAZOLE
- CAS: 1030269-34-1
- MF: C9H2F14N2
- MW: 404.1
- EINECS:
- MDL Number:MFCD06246012
- Synonyms:3,5-BIS(PERFLUOROPROPYL)PYRAZOLE;3,5-Bis(heptafluoropropyl)pyrazole;1H-Pyrazole, 3,5-bis(1,1,2,2,3,3,3-heptafluoropropyl)-;3,5-bis(1,1,2,2,3,3,3-heptafluoropropyl)-1H-pyrazole;3,5-Bis(perfluoropropyl)-1H-pyrazole
5 prices
Selected condition:
Brand
- AK Scientific
- Matrix Scientific
- SynQuest Laboratories
- TRC
Package
- 10mg
- 100mg
- 1g
- 25g
- ManufacturerAK Scientific
- Product number7716AC
- Product description3,5-Bis(perfluoropropyl)pyrazole
- Packaging1g
- Price$125
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number012832
- Product description3,5-Bis(perfluoropropyl)pyrazole 97%
- Packaging1g
- Price$56
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number3H32-3-1F
- Product description3,5-Bis(heptafluoropropyl)pyrazole
- Packaging25g
- Price$725
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB443775
- Product description3,5-Bis(perfluoropropyl)pyrazole
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB443775
- Product description3,5-Bis(perfluoropropyl)pyrazole
- Packaging100mg
- Price$65
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 7716AC | 3,5-Bis(perfluoropropyl)pyrazole | 1g | $125 | 2021-12-16 | Buy |
Matrix Scientific | 012832 | 3,5-Bis(perfluoropropyl)pyrazole 97% | 1g | $56 | 2021-12-16 | Buy |
SynQuest Laboratories | 3H32-3-1F | 3,5-Bis(heptafluoropropyl)pyrazole | 25g | $725 | 2021-12-16 | Buy |
TRC | B443775 | 3,5-Bis(perfluoropropyl)pyrazole | 10mg | $45 | 2021-12-16 | Buy |
TRC | B443775 | 3,5-Bis(perfluoropropyl)pyrazole | 100mg | $65 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|